Modified SMILE (mSMILE) is active in the treatment of pediatric Epstein-Barr virus-associated natural killer/T-cell lymphoma: a single center experience, case series
Article in Translational Pediatrics (July 2024)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in Translational Pediatrics (July 2024)
Article in Clinical Immunology (June 2024)
Article in Journal of Clinical Medicine (May 2024)